Key Notes on Revised Schedule M: Point No. 4 – Sanitation and Hygiene

Maintain strict sanitation and hygiene standards throughout the entire drug manufacturing process.

136
Key Notes Revised Schedule M
Key Notes Revised Schedule M
Rakesh Dahiya

Last Updated on December 16, 2024 by The Health Master

Sanitation and Hygiene

Key considerations for Point No. 4 Sanitation and Hygiene compliance under revised Schedule M are outlined below.

Continued from: Key Notes on Revised Schedule M: Point No. 3 – Good Manufacturing Practice (GMP)

Sanitation and Hygiene Requirements for Pharmaceutical Manufacturers

High Level of Sanitation and Hygiene:

Maintain strict sanitation and hygiene standards throughout the entire drug manufacturing process.

Comprehensive Coverage:

Ensure sanitation and hygiene practices cover all aspects of the manufacturing process, including:

  • Personnel
  • Premises
  • Equipment and apparatus
  • Production materials and containers
  • Cleaning and disinfection agents
  • Any potential source of contamination

Integrated Sanitation and Hygiene Program:

  • Implement a comprehensive program to eliminate potential contamination sources.
  • This program should integrate all sanitation and hygiene aspects into a unified approach.

Compiled by:
Rakesh DahiyaSDCO cum Licensing Authority, FDA Haryana


Next: Key Notes on Revised Schedule M: Point No. 5 – Qualification and validation

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon

For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:

YouTube Icon

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos on consumer awareness, click on the below YouTube icon:

YouTube Icon
Telegram
WhatsApp
Facebook
LinkedIn
YouTube Icon
Google-news